216 related articles for article (PubMed ID: 29235530)
21. Once-Daily Topical Phosphosulindac Is Efficacious in the Treatment of Dry Eye Disease: Studies in Rabbit Models of Its Main Clinical Subtypes.
Huang W; Huang L; Li W; Saglam MS; Tourmouzis K; Goldstein SM; Master A; Honkanen R; Rigas B
J Ocul Pharmacol Ther; 2022; 38(1):102-113. PubMed ID: 34964663
[No Abstract] [Full Text] [Related]
22. Cevimeline-induced anti-inflammatory effect through upregulations of mucins in the ocular surface of a dry eye mouse model.
Kim CE; Kim YJ; Hwang MW; Park YJ; Yang J
Biomed Pharmacother; 2021 Jul; 139():111571. PubMed ID: 33857915
[TBL] [Abstract][Full Text] [Related]
23. ICAM-1 expression predisposes ocular tissues to immune-based inflammation in dry eye patients and Sjögrens syndrome-like MRL/lpr mice.
Gao J; Morgan G; Tieu D; Schwalb TA; Luo JY; Wheeler LA; Stern ME
Exp Eye Res; 2004 Apr; 78(4):823-35. PubMed ID: 15037117
[TBL] [Abstract][Full Text] [Related]
24. [A new approach for better comprehension of diseases of the ocular surface].
Baudouin C
J Fr Ophtalmol; 2007 Mar; 30(3):239-46. PubMed ID: 17417148
[TBL] [Abstract][Full Text] [Related]
25. Dynamic ocular surface and lacrimal gland changes induced in experimental murine dry eye.
Xiao B; Wang Y; Reinach PS; Ren Y; Li J; Hua S; Lu H; Chen W
PLoS One; 2015; 10(1):e0115333. PubMed ID: 25590134
[TBL] [Abstract][Full Text] [Related]
26. Proteoglycan 4 (PRG4) expression and function in dry eye associated inflammation.
Menon NG; Goyal R; Lema C; Woods PS; Tanguay AP; Morin AA; Das N; Jay GD; Krawetz RJ; Dufour A; Shapiro LH; Redfern RL; Ghosh M; Schmidt TA
Exp Eye Res; 2021 Jul; 208():108628. PubMed ID: 34048779
[TBL] [Abstract][Full Text] [Related]
27. Dry eye syndromes.
Barabino S; Dana MR
Chem Immunol Allergy; 2007; 92():176-184. PubMed ID: 17264493
[TBL] [Abstract][Full Text] [Related]
28. Denervation of the Lacrimal Gland Leads to Corneal Hypoalgesia in a Novel Rat Model of Aqueous Dry Eye Disease.
Aicher SA; Hermes SM; Hegarty DM
Invest Ophthalmol Vis Sci; 2015 Oct; 56(11):6981-9. PubMed ID: 26513503
[TBL] [Abstract][Full Text] [Related]
29. Immune profile of squamous metaplasia development in autoimmune regulator-deficient dry eye.
Chen YT; Li S; Nikulina K; Porco T; Gallup M; McNamara N
Mol Vis; 2009; 15():563-76. PubMed ID: 19365590
[TBL] [Abstract][Full Text] [Related]
30. Tear biomarkers in dry eye disease: Progress in the last decade.
Kumar NR; Praveen M; Narasimhan R; Khamar P; D'Souza S; Sinha-Roy A; Sethu S; Shetty R; Ghosh A
Indian J Ophthalmol; 2023 Apr; 71(4):1190-1202. PubMed ID: 37026250
[TBL] [Abstract][Full Text] [Related]
31. A Rabbit Model of Aqueous-Deficient Dry Eye Disease Induced by Concanavalin A Injection into the Lacrimal Glands: Application to Drug Efficacy Studies.
Honkanen RA; Huang L; Rigas B
J Vis Exp; 2020 Jan; (155):. PubMed ID: 32065120
[TBL] [Abstract][Full Text] [Related]
32. Rebamipide ophthalmic solution modulates the ratio of T helper cell 17/regulatory T cells in dry eye disease mice.
Fu R; Jiang Y; Zhou J; Zhang J
Mol Med Rep; 2019 May; 19(5):4011-4018. PubMed ID: 30896815
[TBL] [Abstract][Full Text] [Related]
33. Autoimmunity in dry eye is due to resistance of Th17 to Treg suppression.
Chauhan SK; El Annan J; Ecoiffier T; Goyal S; Zhang Q; Saban DR; Dana R
J Immunol; 2009 Feb; 182(3):1247-52. PubMed ID: 19155469
[TBL] [Abstract][Full Text] [Related]
34. The artemisinin analog SM934 alleviates dry eye disease in rodent models by regulating TLR4/NF-κB/NLRP3 signaling.
Yang FM; Fan D; Yang XQ; Zhu FH; Shao MJ; Li Q; Liu YT; Lin ZM; Cao SQ; Tang W; He SJ; Zuo JP
Acta Pharmacol Sin; 2021 Apr; 42(4):593-603. PubMed ID: 32747720
[TBL] [Abstract][Full Text] [Related]
35. Single-cell landscape reveals the epithelial cell-centric pro-inflammatory immune microenvironment in dry eye development.
Liu Z; Xie H; Li L; Jiang D; Qian Y; Zhu X; Dai M; Li Y; Wei R; Luo Z; Xu W; Zheng Q; Shen J; Zhou M; Zeng W; Chen W
Mucosal Immunol; 2024 Jun; 17(3):491-507. PubMed ID: 38007004
[TBL] [Abstract][Full Text] [Related]
36. Ocular surface changes in mice with streptozotocin-induced diabetes and diabetic polyneuropathy.
Schicht M; Farger J; Wedel S; Sisignano M; Scholich K; Geisslinger G; Perumal N; Grus FH; Singh S; Sahin A; Paulsen F; Lütjen-Drecoll E
Ocul Surf; 2024 Jan; 31():43-55. PubMed ID: 38141818
[TBL] [Abstract][Full Text] [Related]
37. Capsanthin from Capsicum annum fruits exerts anti-glaucoma, antioxidant, anti-inflammatory activity, and corneal pro-inflammatory cytokine gene expression in a benzalkonium chloride-induced rat dry eye model.
Shanmugham V; Subban R
J Food Biochem; 2022 Oct; 46(10):e14352. PubMed ID: 35892258
[TBL] [Abstract][Full Text] [Related]
38. Ocular surface immunity: homeostatic mechanisms and their disruption in dry eye disease.
Barabino S; Chen Y; Chauhan S; Dana R
Prog Retin Eye Res; 2012 May; 31(3):271-85. PubMed ID: 22426080
[TBL] [Abstract][Full Text] [Related]
39. Mesenchymal stem/stromal cells protect the ocular surface by suppressing inflammation in an experimental dry eye.
Lee MJ; Ko AY; Ko JH; Lee HJ; Kim MK; Wee WR; Khwarg SI; Oh JY
Mol Ther; 2015 Jan; 23(1):139-46. PubMed ID: 25152016
[TBL] [Abstract][Full Text] [Related]
40. Effect of Rapamycin Microspheres in Sjögren Syndrome Dry Eye: Preparation and Outcomes.
Wang S; Wang M; Liu Y; Hu D; Gu L; Fei X; Zhang J
Ocul Immunol Inflamm; 2019; 27(8):1357-1364. PubMed ID: 30273514
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
